Phase 2a Study of VX-407 in Participants With ADPKD Who Have a Subset of PKD1 Gene Variants (AGLOW)
Clinical trial NCT07161037 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT07161037
- Sponsor
- Vertex Pharmaceuticals Incorporated
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-11-19
- Primary completion
- 2027-07-22
- Enrollment
- 26
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.